360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

BTG plc

Type: Company

Name: BTG plc

Nationality: United Kingdom

Web Address: http://www.btgplc.com/

Fact Sheet: Fact Sheet for BTG plc

First reported 16 hours ago - Updated 16 hours ago - 1 reports

Director/PDMR Shareholding

BTG plc: Directors' Awards under the BTG Deferred Share Bonus Plan 2006On 28 May 2010 the Company made the following grants of awards over ordinary shares in the Company under the BTG Deferred Share Bonus Plan 2006: Louise Makin 98386 Rolf Soderstrom ... [Published TrustNet - 16 hours ago]

Entities: BTG plc, Louise Makin, Andy Burrows

First reported 17 hours ago - Updated 17 hours ago - 1 reports

3i Group Plc

Europe Earnings: 3i Group, BTG, Close Brothers, Elan

3:20 PM Frankfurt – 3i Group offers to acquire Barclays European infrastructure fund division. BTG agreed to acquire targeted therapies division of Nordion for £133 million and also signed agreement to buy the EKOS valued £120 million. Close Brothers ... [Published Ticker - 17 hours ago]

Entities: BTG plc, 3i Group Plc, Close Brothers Group plc, Élan Corporation plc

First reported May 24 2013 - Updated May 24 2013 - 1 reports

BTG to Buy EKOS, Maker of Clot-Removing Device, for Up To $220M

EKOS Corp ., which rounded up more than $100 million in venture capital and emerged as a profitable seller of clot-removing medical devices, has agreed to be acquired by BTG PLC for up to $220 million in cash and milestones.EKOS, whose technology removes ... [Published Dow Jones Financial Information Services - May 24 2013]

Entities: BTG plc, Anticoagulant, Thrombosis

First reported May 23 2013 - Updated May 23 2013 - 1 reports

BTG plc

BTG plc (BTG.L) Buys Ekos for Up to $420 Mllion

-- A fast-growing and profitable interventional vascular business BTG plc (BTG or the Company), the specialist healthcare company, is pleased to announce that it has entered into an agreement to buy EKOS Corporation (EKOS) a fast growing and profitable ... [Published BioSpace - May 23 2013]

Entities: BTG plc, Interference, Health Care

First reported May 23 2013 - Updated May 23 2013 - 1 reports

BTG raises capital, makes two acquisitions

BTG Plc has raised a gross £106.3 million in a share placement with institutional investors to partially fund two North American acquisitions that will strengthen the British company’s presence in the hospital market.The financing involves the placement ... [Published MedNous - May 23 2013]

Entities: BTG plc, Acquisition, Nordion Inc

First reported May 23 2013 - Updated May 23 2013 - 1 reports

BTG snaps up new technologies in $420M deal splurge

In a bid to join the billion-dollar sales club, the U.K.'s BTG has snapped up a pair of operations with new delivery tech and a treatment for deep vein thrombosis for up to $420 million--most of that in cash. And it's selling a chunk of shares to help ... [Published FierceBiotech - May 23 2013]

Entities: BTG plc, Interference, Liver Cancer, Coagulation

First reported May 23 2013 - Updated May 23 2013 - 2 reports

Manufacturing

Nordion Inc Enters Into Agreement To Divest Targeted Therapies Business To BTG Plc

7:00am BSTNordion Inc announced that it has entered into an agreement to divest its Targeted Therapies business to BTG Plc for a cash purchase price of USD200 million. Net of cash taxes and transaction costs, Nordion expects to realize approximately USD185 ... [Published Reuters UK - May 23 2013]

Entities: BTG plc, Nordion Inc, Manufacturing, Liver Cancer

First reported May 23 2013 - Updated May 23 2013 - 1 reports

UKs specialty pharma firm BTG spends $380 million on two acquisitions

British specialty pharma company BTG Plc today agreed to spend $380 million on two acquisitions in order to create an interventional medicine business with potential sales of $1 billion.The London-based company will buy US-based Ekos Corp, a fast growing ... [Published domain-b - May 23 2013]

Entities: BTG plc, Liver Cancer, Coagulation

First reported May 23 2013 - Updated May 23 2013 - 2 reports

U.K. Stocks Drop From 13-Year High as China Manufacturing Falls

U.K. stocks dropped from the highest level since December 1999, as concern grew the Federal Reserve will scale back its stimulus measures if the U.S. economy improves and as data showed Chinese manufacturing contracted.St James’s Place Plc plunged 9.8 ... [Published BusinessWeek - May 23 2013]

Entities: Manufacturing, China, Index

First reported May 23 2013 - Updated May 23 2013 - 1 reports

BTG To Buy EKOS; Proposes To Acquire Theraspher

Heathcare company BTG (BTG.L) Thursday said it has entered into an agreement to buy EKOS Corporation, an interventional vascular business, on a debt free, cash free basis. BTG will initially pay cash of approximately $180 million and subsequently up to ... [Published RTTNews.com - May 23 2013]

Entities: BTG plc, Interference, Acquisition, Nordion Inc

First reported May 23 2013 - Updated May 23 2013 - 2 reports

BTG plc: Proposed Placing or Ordinary New Shares

BTG PLC1 Converted at an exchange rate of 1.506 on 22 May 2013. 1 representatives, including the planned Varisolve$ (PEM) field force, providing revenue benefits and cross-selling opportunities.We firmly believe that the two acquisitions announced today ... [Published Noodls - May 23 2013]

Entities: BTG plc, Stocks, Earnings Per Share, FTI Consulting Inc, Acquisition

First reported May 23 2013 - Updated May 23 2013 - 1 reports

BTG builds interventional medicine platform with deals

Home » Syndicated Content » LONDON, May 23 (Reuters) - Britain's BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an interventional medicine business with ... [Published BioPortfolio - May 23 2013]

Entities: BTG plc, Interference, Biotechnology, Consortium

Quotes

...nterventional medicine, we believe it is an ideal home for TheraSphere and the talented people that support it," CEO Steve West said in a statement. "... We intend to continue our strategic review process which includes an assessment of potential uses for the cash proceeds from this sale."

Nordion sells off drug unit for $200M, focuses on contracting [Published FiercePharma - May 24 2013]

...build on our existing interventional oncology business and to create a commercial and scientific leader in the sector," says Louise Makin, the CEO. "We believe that the combination will be highly beneficial to both patients and physicians as it brings together expertise that will be applied to the development and use of locoregional therapies for liver cancer."

BTG snaps up new technologies in $420M deal splurge [Published FierceBiotech - May 23 2013]

"We have delivered strong financial results which reflect the successful transition of our business into a commercially focused, specialist healthcare company that makes and markets its own products."

Sales Jump 19% At BTG Plc [Published Motley Fool UK - May 20 2013]

...anofi/Genzyme's Lemtrada? (alemtuzumab) under review in the US and EU for multiple sclerosis Louise Makin, BTG's Chief Executive Officer, commented: "We have delivered strong financial results which reflect the successful transition of our business into a commercially focused, specialist healthcare company that makes and markets its own products. We are on track with our growth strategy, and are investing in our Beads business, preparing for a potential H1 2014 US approval and launch of Varisolve$ and actively seeking opportunities to add new products and programmes. Overall, we have the financial resources and capabilities to continue to build the business and deliver our growth strategy." Andy Burrows, Director of Investor Relations

BTG plc: Final Results [Published Noodls - May 20 2013]

More Content

sort by: Date \| Relevance
Director/PDMR Shareholding [Published TrustNet - 16 hours ago]
Europe Earnings: 3i Group, BTG, Close Brothers,... [Published Ticker - 17 hours ago]
Deals Of The Week Ponders When $2.1 Billion Is ... [Published The IN VIVO Blog - 17 hours ago]
AVIVA PLC: BTG PLC - Holding(s) in Company [Published 4 Traders - 17 hours ago]
Nordion sells off drug unit for $200M, focuses ... [Published FiercePharma - May 24 2013]
BTG to Buy EKOS, Maker of Clot-Removing Device,... [Published Dow Jones Financial Information Services - May 24 2013]
BTG plc (BTG.L) Buys Ekos for Up to $420 Mllion [Published BioSpace - May 23 2013]
BTG raises capital, makes two acquisitions [Published MedNous - May 23 2013]
Nordion shares jump 11 percent after news on sa... [Published Yahoo! UK and Ireland - May 23 2013]
BTG snaps up new technologies in $420M deal spl... [Published FierceBiotech - May 23 2013]
Nordion suscribe acuerdo para ceder el negocio ... [Published Business Wire Professional Services News - May 23 2013]
Nordion suscribe acuerdo para ceder el negocio ... [Published Business Wire Health News - May 23 2013]
Why United Utilities Group, Booker Group Plc An... [Published Motley Fool UK - May 23 2013]
Results of Placing [Published TrustNet - May 23 2013]
Nordion unterzeichnet Vertrag über Verkauf sein... [Published Business Wire Professional Services News - May 23 2013]
Nordion unterzeichnet Vertrag über Verkauf sein... [Published Business Wire Health News - May 23 2013]
Nordion to Sell Targeted Therapies Business to ... [Published Benzinga.com - May 23 2013]
UKs specialty pharma firm BTG spends $380 milli... [Published domain-b - May 23 2013]
Nordion passe un accord pour céder des thérapie... [Published Business Wire Professional Services News - May 23 2013]
Nordion passe un accord pour céder des thérapie... [Published Business Wire Health News - May 23 2013]
U.K. Stocks Drop From 13-Year High as China Man... [Published BusinessWeek - May 23 2013]
BTG To Buy EKOS; Proposes To Acquire Theraspher [Published RTTNews.com - May 23 2013]
U.K. Stocks Drop From 13-Year High on China Eco... [Published Bloomberg - May 23 2013]
BTG plc: Proposed Placing or Ordinary New Shares [Published Noodls - May 23 2013]
BTG builds interventional medicine platform wit... [Published BioPortfolio - May 23 2013]
Nordion sottoscrive accordo per cedere attività... [Published Business Wire Professional Services News - May 23 2013]
Nordion sluit overeenkomst met BTG plc voor ver... [Published Business Wire Professional Services News - May 23 2013]
Nordion sottoscrive accordo per cedere attività... [Published Business Wire Health News - May 23 2013]
Nordion sluit overeenkomst met BTG plc voor ver... [Published Business Wire Health News - May 23 2013]
BTG plc: Proposed Placing or Ordinary New Shares [Published BTG - May 23 2013]

Blogs

sort by: Date \| Relevance
Deals Of The Week Ponders When $2.1 Billion Is ... [Published The IN VIVO Blog - 17 hours ago] With the oncology high season upon us and just about everyone in the industry scrambling to decode the secrets hidden in ASCO’s abstracts, we couldn’t help but stop and reflect on how at least one company got where it is in oncology today through stellar ...
A Big Year for Novel Drugs Approvals [Published I Am Biotech - Jan 17 2013] What was your top Biopharma highlight for 2012? If it wasn’t the stellar move in the AMEX Biotech Index (up 42%), or the reauthorization of PDUFA, then perhaps it was the decade high for innovative drugs approvals. We would need to go back to the 1990s ...

Press Releases

sort by: Date \| Relevance
Nordion suscribe acuerdo para ceder el negocio ... [Published Business Wire Professional Services News - May 23 2013]
Nordion suscribe acuerdo para ceder el negocio ... [Published Business Wire Health News - May 23 2013]
Nordion unterzeichnet Vertrag über Verkauf sein... [Published Business Wire Professional Services News - May 23 2013]
Nordion unterzeichnet Vertrag über Verkauf sein... [Published Business Wire Health News - May 23 2013]
Nordion passe un accord pour céder des thérapie... [Published Business Wire Professional Services News - May 23 2013]